Case report: Successful treatment of a patient with relapsed/refractory primary central nervous system lymphoma with thiotepa-based induction, autologous stem cell transplantation and maintenance

Despite significant improvements in prognosis, a subset of patients with primary central nervous system lymphoma (PCNSL) remains at high risk for relapse. The treatment of relapsed and refractory (R/R) PCNSL remains a major clinical challenge. Herein, we present a 24-year-old patient with PCNSL who...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Luyao Wang, Yili Fan, Boxiao Chen, Jiawei Zhang, Luyu Yang, Xi Qiu, Huawei Jiang, Jinfan Li, Xibin Xiao, Liansheng Huang, Yang Xu
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2024-01-01
Saila:	Frontiers in Oncology
Gaiak:	primary central nervous system lymphoma thiotepa autologous stem cell transplantation anti-PD-1 antibody maintenance therapy
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1333761/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!